Canada markets close in 3 hours 10 minutes

Luye Pharma Group Ltd. (LUP.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
0.3500+0.0060 (+1.74%)
As of 08:03AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 1.34B
Enterprise Value 1.33B
Trailing P/E 18.74
Forward P/E 18.35
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.63
Price/Book (mrq)0.80
Enterprise Value/Revenue 0.22
Enterprise Value/EBITDA 0.64

Trading Information

Stock Price History

Beta (5Y Monthly) 0.81
52-Week Change 3-20.00%
S&P500 52-Week Change 325.77%
52 Week High 30.4620
52 Week Low 30.2840
50-Day Moving Average 30.3274
200-Day Moving Average 30.3763

Share Statistics

Avg Vol (3 month) 3170
Avg Vol (10 day) 31.02k
Shares Outstanding 53.76B
Implied Shares Outstanding 63.89B
Float 81.95B
% Held by Insiders 133.47%
% Held by Institutions 130.39%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jun 29, 2020
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 8.67%
Operating Margin (ttm)21.00%

Management Effectiveness

Return on Assets (ttm)2.23%
Return on Equity (ttm)4.39%

Income Statement

Revenue (ttm)6.14B
Revenue Per Share (ttm)1.65
Quarterly Revenue Growth (yoy)3.50%
Gross Profit (ttm)N/A
EBITDA 1.55B
Net Income Avi to Common (ttm)532.6M
Diluted EPS (ttm)0.0200
Quarterly Earnings Growth (yoy)24.30%

Balance Sheet

Total Cash (mrq)6.11B
Total Cash Per Share (mrq)1.62
Total Debt (mrq)8.42B
Total Debt/Equity (mrq)62.27%
Current Ratio (mrq)1.32
Book Value Per Share (mrq)3.33

Cash Flow Statement

Operating Cash Flow (ttm)1.6B
Levered Free Cash Flow (ttm)716.76M